サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1126871

ナルコレプシー治療薬の世界市場規模、シェア、産業動向分析レポート：タイプ別、製品別、地域別展望と予測、2022年～2028年

Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product, By Regional Outlook and Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 170 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ナルコレプシー治療薬の世界市場規模、シェア、産業動向分析レポート：タイプ別、製品別、地域別展望と予測、2022年～2028年
出版日: 2022年08月31日
発行: KBV Research
ページ情報: 英文 170 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナルコレプシー治療薬の世界市場規模は、予測期間中にCAGR10.5%の市場成長率で上昇し、2028年には50億米ドルに達すると予測されます。

ナルコレプシーに関連するEDSの治療薬として、EUおよび米国で最近承認されたのは、ドーパミンおよびノルエピネフリン再取り込み阻害薬のソリアムフェトールと、H3R拮抗薬のピトリザントです。EDSやナルコレプシーに伴うカタプレキシーの治療薬として、多くの新薬が開発・試験されており、新規オキシベートの低ナトリウム型製剤（FT218）、一晩型製剤（JZP-258）、選択的ノルエピネフリン再取り込み阻害剤（AXS-12）、modafinilやアストログリアコネキシン阻害剤（THN102）などがあります。

最近認可されたナルコレプシーの治療薬および開発中の治療薬の作用機序、薬物動態、有効性、安全性／忍容性を紹介。ナルコレプシーと呼ばれる過眠を伴う慢性的な神経疾患は、全世界で10万人あたり20～67人が罹患していると考えられています。ナルコレプシーは、通常、人生の第二十年代に始まりますが、診断がつくのがずっと遅くなることもよくあります。

日中の過度の眠気（EDS）は、ナルコレプシー特有の症状ではありませんが、診断のためには全ての人に見られる必要があります。また、60％以上の患者さんにカタプレキシーがみられます。カタプレキシーは、起きているときに筋肉の緊張が不随意に低下する症状で、一般に強い情動によって引き起こされます。また、落ち着かない夜、入眠時と起床時に起こる幻覚（hypnagogic and hypnopompic hallucies）、睡眠麻痺も他の症状として挙げられます。

COVID-19の影響分析

パンデミック時、COVID-19はナルコレプシー治療薬に悪影響を及ぼしました。最大の問題は、ナルコレプシーの患者さんが、交通機関の制限、自宅での検疫、病院での交差感染の恐れなどから、処方箋を記入してもらうことができず、薬を飲むことをやめてしまうことです。さらに、COVID-19には有効な治療法がないため、メーカーや企業はCOVID-19の治療に必要な医薬品やツールの生産に、より一層力を入れているのです。

市場の成長要因

ヘルスケア支出の増加

市場拡大の主な要因の1つは、各国政府によるヘルスケア分野への投資額とその規模が拡大していることです。途上国の急速な経済発展や医療費の増大により、質の高いヘルスケアへのアクセスがより一層拡大することが予想されるためです。このことは、ナルコレプシー治療薬業界にとって、拡大のためのポジティブな指標と見なされています。これらの国々では、不眠症の問題が増加しているため、さまざまな治療法や器具のニーズが急増しています。

神経学的条件の有病率の増加

神経科医は、ナルコレプシー、睡眠時無呼吸症候群、レストレスレッグス症候群、不眠症、睡眠時無呼吸症候群など、さまざまな睡眠問題を治療しています。内因性の不規則性は、いくつかの病気によってもたらされ、規則的な睡眠と覚醒のサイクルを妨げます。今後数年間は、人口のかなりの部分が高齢化するため、神経性の睡眠関連疾患が増加すると予測されています。米国国立衛生研究所（NIH）は、2,000万人のアメリカ人が時々睡眠の問題を抱えていると推定しており、一方、4,000万人のアメリカ人が神経系の病気に苦しんでいると推定しています。

市場抑制要因

ナルコレプシーの診断と治療における高いコスト

ナルコレプシー市場を阻害する主な要因の1つは、ナルコレプシーの診断と治療にかかる費用が高いということです。さらに、「睡眠問題」という言葉は、個人の健康に深刻な悪影響を及ぼし、莫大な社会的コストを伴う幅広い病気を指します。さらに2019年、ナルコレプシー市場の円滑な運営は、高い治療費によって阻害されます。日常的な機能はナルコレプシーによって阻害され、それはまた、大きな経済的・医療的負担-多くの患者が完全な障害者であること-と結びついているのです。

タイプ別の展望

ナルコレプシー治療薬の市場は、タイプ別に、カタプレキーを伴うナルコレプシー、カタプレキーを伴わないナルコレプシー、二次性ナルコレプシーに区分されます。2021年のナルコレプシー治療薬市場では、カタプレキシーを伴うナルコレプシーセグメントが最も高い収益シェアを獲得しています。それは、カタプレキシーが患者の間でより一般的な重要な症状になっているためです。予測を通じて、その地位を維持することが予想されます。

製品の展望

製品に基づき、ナルコレプシー治療薬市場は、中枢神経系刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、その他に分類されます。中枢神経系刺激剤セグメントは、2021年のナルコレプシー治療薬市場において、かなりの収益シェアを記録しています。中枢神経系薬剤のデータ分析では、成人のナルコレプシー患者における日中の過度の眠気（EDS）およびカタプレキシに対するピトリサントへの反応発現までの時間を評価するためです。

地域別の展望

地域別に見ると、ナルコレプシー治療薬市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。アジア太平洋地域は、2021年のナルコレプシー治療薬市場において有望な収益シェアを獲得しました。これは、経済成長、国民の意識の高まり、可処分所得の高さ、製薬・バイオテクノロジー産業への投資の増加、政府の篤志的な取り組みによるものです。アジア太平洋諸国の中でも、日本はナルコレプシーの有病率が高いことが指摘されています。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場規模
  • セグメンテーション
    • ナルコレプシー治療薬の世界市場、タイプ別
    • ナルコレプシー治療薬の世界市場、製品別
    • ナルコレプシー治療薬の世界市場、地域別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要の説明
      • 市場の構成とシナリオ
  • 市場に影響を与える主要因
    • 市場促進要因
    • 市場の抑制要因

第3章 ナルコレプシー治療薬の世界市場：タイプ別

  • カタプレキシーを伴うナルコレプシーの世界市場：地域別
  • カタプレキシーを伴わないナルコレプシーの世界市場：地域別
  • 二次性ナルコレプシーの世界市場：地域別

第4章 ナルコレプシー治療薬の世界市場：製品別

  • オキシベートナトリウムの世界市場：地域別
  • 選択的セロトニン再取り込み阻害剤の世界市場：地域別
  • 中枢神経系刺激薬の世界市場：地域別
  • 三環系抗うつ薬の世界市場：地域別
  • その他の地域別世界市場

第5章 ナルコレプシー治療薬の世界市場：地域別

  • 北米
    • 北米のナルコレプシー治療薬市場：国別
      • 米国
      • カナダ
      • メキシコ
      • 北米以外の地域
  • 欧州
    • 欧州のナルコレプシー治療薬市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域のナルコレプシー治療薬市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAのナルコレプシー治療薬市場：国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • LAMEAの他の地域

第6章 企業プロファイル

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer, Inc.（Arena Pharmaceuticals, Inc.）
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.
図表

LIST OF TABLES

  • TABLE 1 Global Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 2 Global Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 3 Global Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Narcolepsy with Cataplexy Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Narcolepsy with Cataplexy Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Narcolepsy Without Cataplexy Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Narcolepsy Without Cataplexy Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Secondary Narcolepsy Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Secondary Narcolepsy Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 12 Global Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 13 Global Sodium Oxybate Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Sodium Oxybate Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Selective Serotonin Reuptake Inhibitor Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Selective Serotonin Reuptake Inhibitor Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Central Nervous System Stimulants Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Central Nervous System Stimulants Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Tricyclic Antidepressants Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Tricyclic Antidepressants Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Narcolepsy Therapeutics Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Narcolepsy Therapeutics Market by Region, 2022 - 2028, USD Million
  • TABLE 25 North America Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 26 North America Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 27 North America Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 28 North America Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 29 North America Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 36 North America Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 37 North America Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 49 US Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 50 US Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 51 US Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 52 US Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 53 US Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 54 US Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 55 Canada Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 56 Canada Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 57 Canada Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 58 Canada Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 59 Canada Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 60 Canada Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 61 Mexico Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 62 Mexico Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 63 Mexico Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 64 Mexico Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Mexico Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 66 Mexico Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 67 Rest of North America Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 68 Rest of North America Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 69 Rest of North America Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 70 Rest of North America Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 71 Rest of North America Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 72 Rest of North America Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 73 Europe Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 74 Europe Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 75 Europe Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 76 Europe Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 77 Europe Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 82 Europe Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 83 Europe Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 84 Europe Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 85 Europe Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 86 Europe Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 87 Europe Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 88 Europe Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 89 Europe Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Europe Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 92 Europe Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 93 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Germany Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 98 Germany Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 99 Germany Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 100 Germany Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 101 Germany Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Germany Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 103 UK Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 104 UK Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 105 UK Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 106 UK Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 107 UK Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 108 UK Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 109 France Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 110 France Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 111 France Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 112 France Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 113 France Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 114 France Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 115 Russia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 116 Russia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 117 Russia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 118 Russia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 119 Russia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 120 Russia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 121 Spain Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 122 Spain Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 123 Spain Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Spain Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 125 Spain Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 126 Spain Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 127 Italy Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 128 Italy Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 129 Italy Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 130 Italy Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 131 Italy Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 132 Italy Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 133 Rest of Europe Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 134 Rest of Europe Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 135 Rest of Europe Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 136 Rest of Europe Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 137 Rest of Europe Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 138 Rest of Europe Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 147 Asia Pacific Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Asia Pacific Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 150 Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 151 Asia Pacific Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 152 Asia Pacific Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 153 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 155 Asia Pacific Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 156 Asia Pacific Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 157 Asia Pacific Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 158 Asia Pacific Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 159 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 160 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 161 Asia Pacific Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 162 Asia Pacific Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 163 China Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 164 China Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 165 China Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 166 China Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 167 China Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 168 China Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 169 Japan Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 170 Japan Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 171 Japan Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 172 Japan Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 173 Japan Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 174 Japan Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 175 India Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 176 India Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 177 India Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 178 India Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 179 India Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 180 India Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 181 South Korea Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 182 South Korea Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 183 South Korea Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 184 South Korea Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 185 South Korea Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 186 South Korea Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 187 Singapore Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 188 Singapore Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 189 Singapore Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 190 Singapore Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 191 Singapore Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 192 Singapore Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 193 Malaysia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 194 Malaysia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 195 Malaysia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 196 Malaysia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 197 Malaysia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 198 Malaysia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 199 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 200 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 201 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 202 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 203 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 204 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 205 LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 206 LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 209 LAMEA Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 210 LAMEA Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 211 LAMEA Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
  • TABLE 212 LAMEA Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
  • TABLE 213 LAMEA Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
  • TABLE 214 LAMEA Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
  • TABLE 215 LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 216 LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 217 LAMEA Sodium Oxybate Market by Country, 2018 - 2021, USD Million
  • TABLE 218 LAMEA Sodium Oxybate Market by Country, 2022 - 2028, USD Million
  • TABLE 219 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 220 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 221 LAMEA Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
  • TABLE 222 LAMEA Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
  • TABLE 223 LAMEA Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
  • TABLE 224 LAMEA Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
  • TABLE 225 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 226 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 227 LAMEA Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 228 LAMEA Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 229 Brazil Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 230 Brazil Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 231 Brazil Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 232 Brazil Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 233 Brazil Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 234 Brazil Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 235 Argentina Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 236 Argentina Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 237 Argentina Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 238 Argentina Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 239 Argentina Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 240 Argentina Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 241 UAE Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 242 UAE Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 243 UAE Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 244 UAE Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 245 UAE Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 246 UAE Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 247 Saudi Arabia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 248 Saudi Arabia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 249 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 250 Saudi Arabia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 251 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 252 Saudi Arabia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 253 South Africa Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 254 South Africa Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 255 South Africa Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 256 South Africa Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 257 South Africa Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 258 South Africa Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 259 Nigeria Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 260 Nigeria Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 261 Nigeria Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 262 Nigeria Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 263 Nigeria Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 264 Nigeria Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 265 Rest of LAMEA Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
  • TABLE 266 Rest of LAMEA Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
  • TABLE 267 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
  • TABLE 268 Rest of LAMEA Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
  • TABLE 269 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
  • TABLE 270 Rest of LAMEA Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
  • TABLE 271 Key Information - Jazz Pharmaceuticals plc
  • TABLE 272 Key Information - Shionogi & Co., Ltd.
  • TABLE 273 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 274 Key Information - Pfizer, Inc.
  • TABLE 275 Key Information - Bioprojet
  • TABLE 276 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 277 Key Information - Ligand Pharmaceuticals, Inc.
  • TABLE 278 Key Information - Graymark Healthcare, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Narcolepsy Therapeutics Market Share by Type, 2021
  • FIG 3 Global Narcolepsy Therapeutics Market Share by Type, 2028
  • FIG 4 Global Narcolepsy Therapeutics Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Narcolepsy Therapeutics Market Share by Product, 2021
  • FIG 6 Global Narcolepsy Therapeutics Market Share by Product, 2028
  • FIG 7 Global Narcolepsy Therapeutics Market by Product, 2018 - 2028, USD Million
  • FIG 8 Global Narcolepsy Therapeutics Market Share by Region, 2021
  • FIG 9 Global Narcolepsy Therapeutics Market Share by Region, 2028
  • FIG 10 Global Narcolepsy Therapeutics Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Jazz Pharmaceuticals PLC
目次

The Global Narcolepsy Therapeutics Market size is expected to reach $5 billion by 2028, rising at a market growth of 10.5% CAGR during the forecast period.

Chronic, incapacitating neurologic disease called narcolepsy is characterized by excessive daytime sleepiness (EDS). Modafinil, armodafinil, and stimulants are only a few of the medications used to treat narcolepsy. Others include sodium oxybate and venlafaxine, which are used to treat the symptoms of sleep paralysis and sleep-related hallucinations (e.g. sodium oxybate).

In general, drugs that boost norepinephrine or dopamine release or prevent their reuptake have wake-promoting effects and can help manage EDS, whereas drugs that block serotonin or norepinephrine reuptake have anti-cataplexy benefits. Both EDS and cataplexy are affected by the modification of either histamine H3 receptors (H3Rs) or -aminobutyric acid B (GABAB) receptors.

The most recent approved medications for EDS related to narcolepsy in the European Union and the USA are solriamfetol, a dopamine and norepinephrine reuptake inhibitor, and pitolisant, an H3R antagonist. Many new drugs are being developed and tested as potential treatments for EDS and cataplexy associated with narcolepsy (THN102), including novel Oxybate formulations of low sodium [FT218] and one-nightly [JZP-258], selective norepinephrine reuptake inhibitors (AXS-12), and modafinil and astroglial connexin inhibitors (THN102).

The mechanisms of action, pharmacokinetics, effectiveness, and safety/tolerability of recently authorized and developing therapies for narcolepsy. A chronic, incapacitating neurologic condition of hypersomnolence called narcolepsy is thought to affect 20-67 persons per 100,000 people across the world. Narcolepsy typically begins in the second decade of life; however, a diagnosis is frequently made much later.

Excessive daytime sleepiness (EDS), while not a specific symptom of narcolepsy, is a feature of the illness that must be present in all individuals to make the diagnosis. Up to 60% of patients have cataplexy, an involuntary decrease of muscle tone while awake that is generally brought on by intense emotions. Restless nights, hypnagogic and hypnopompic hallucinations that happen when the user falls asleep and wakes up, and sleep paralysis are other symptoms.

COVID-19 Impact Analysis

During the pandemic, COVID-19 had a detrimental effect on narcolepsy medications. The biggest problem is that patients with narcolepsy can stop taking their medication because they are unable to get their prescriptions filled because of transportation limitations, home quarantines, and hospital cross-infection fears. Additionally, because there is no effective treatment for COVID-19, manufacturers and companies are concentrating more on producing the pharmaceuticals and tools that are required for treating COVID-19.  

Market Growth Factors

Growing Healthcare Expenditures

One of the main factors boosting the market's rise is the rising number and size of investments made in the healthcare sector by governments of various countries. It is anticipated that more developing nations would have greater access to high-quality healthcare as a result of their quick economic development and growing healthcare costs. This is viewed as a positive indicator of expansion for the narcolepsy therapeutics industry. The need for various treatment and apparatus has surged in these nations due to the rising insomnia problems.

Increasing Prevalence Of Neurological Conditions

Neurologists treat a wide variety of sleep problems, including narcolepsy, sleep apnea, restless legs syndrome, insomnia, and sleep apnea. Endogenous irregularities are brought on by several illnesses, which interfere with the regular sleep-wake cycle. In the upcoming years, neurological sleep-related diseases are predicted to rise as a significant section of the population ages. The National Institute of Health (NIH) estimates that 20 million Americans occasionally have sleep issues, whereas 40 million Americans suffer from neurological illnesses.

Market Restraining Factors

High Cost Of Narcolepsy Diagnosis & Treatment

One of the main factors holding back the narcolepsy market is the high cost of narcolepsy diagnosis and treatment. Additionally, the term "sleeping problem" refers to a broad range of illnesses with serious negative effects on the health of the individual and huge societal costs. Furthermore, in 2019 the smooth operation of the narcolepsy market is disrupted by the high cost of therapy. Daily functioning is hampered by narcolepsy, which is also connected with a significant financial and medical burden-many patients are fully disabled.

Type Outlook

On the basis of Type, the Narcolepsy Therapeutics Market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. The Narcolepsy with Cataplexy segment acquired the highest revenue share in the narcolepsy therapeutics market in 2021. It is because cataplexy is becoming a more common significant symptom among patients. Throughout the prediction, it is anticipated to hold onto its position.

Product Outlook

Based on the Product, the Narcolepsy Therapeutics Market is divided into Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake inhibitors, Tricyclic Antidepressants, and Others. The Central Nervous System Stimulants segment recorded a substantial revenue share in the narcolepsy therapeutics market in 2021. It is because the data analysis of CNS Drugs assesses the time to onset of response to pitolisant for excessive daytime sleepiness (EDS) and cataplexy in adult narcolepsy patients.

Regional Outlook

Region-wise, the Narcolepsy Therapeutics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region garnered a promising revenue share in the narcolepsy therapeutics market in 2021. It is due to economic growth, a rise in public awareness, high levels of disposable money, a rise in investments in the pharmaceutical and biotechnology industries, and benevolent government efforts. Among the Asia Pacific nations, Japan has been noted as having a high prevalence of narcolepsy.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Narcolepsy with Cataplexy
  • Narcolepsy Without Cataplexy
  • Secondary Narcolepsy

By Product

  • Sodium Oxybate
  • Selective Serotonin Reuptake Inhibitor
  • Central Nervous System Stimulants
  • Tricyclic Antidepressants
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Jazz Pharmaceuticals plc
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
  • Bioprojet
  • Takeda Pharmaceutical Company Limited
  • Ligand Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Narcolepsy Therapeutics Market, by Type
    • 1.4.2 Global Narcolepsy Therapeutics Market, by Product
    • 1.4.3 Global Narcolepsy Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Narcolepsy Therapeutics Market by Type

  • 3.1 Global Narcolepsy with Cataplexy Market by Region
  • 3.2 Global Narcolepsy Without Cataplexy Market by Region
  • 3.3 Global Secondary Narcolepsy Market by Region

Chapter 4. Global Narcolepsy Therapeutics Market by Product

  • 4.1 Global Sodium Oxybate Market by Region
  • 4.2 Global Selective Serotonin Reuptake Inhibitor Market by Region
  • 4.3 Global Central Nervous System Stimulants Market by Region
  • 4.4 Global Tricyclic Antidepressants Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global Narcolepsy Therapeutics Market by Region

  • 5.1 North America Narcolepsy Therapeutics Market
    • 5.1.1 North America Narcolepsy Therapeutics Market by Type
      • 5.1.1.1 North America Narcolepsy with Cataplexy Market by Country
      • 5.1.1.2 North America Narcolepsy Without Cataplexy Market by Country
      • 5.1.1.3 North America Secondary Narcolepsy Market by Country
    • 5.1.2 North America Narcolepsy Therapeutics Market by Product
      • 5.1.2.1 North America Sodium Oxybate Market by Country
      • 5.1.2.2 North America Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.1.2.3 North America Central Nervous System Stimulants Market by Country
      • 5.1.2.4 North America Tricyclic Antidepressants Market by Country
      • 5.1.2.5 North America Others Market by Country
    • 5.1.3 North America Narcolepsy Therapeutics Market by Country
      • 5.1.3.1 US Narcolepsy Therapeutics Market
        • 5.1.3.1.1 US Narcolepsy Therapeutics Market by Type
        • 5.1.3.1.2 US Narcolepsy Therapeutics Market by Product
      • 5.1.3.2 Canada Narcolepsy Therapeutics Market
        • 5.1.3.2.1 Canada Narcolepsy Therapeutics Market by Type
        • 5.1.3.2.2 Canada Narcolepsy Therapeutics Market by Product
      • 5.1.3.3 Mexico Narcolepsy Therapeutics Market
        • 5.1.3.3.1 Mexico Narcolepsy Therapeutics Market by Type
        • 5.1.3.3.2 Mexico Narcolepsy Therapeutics Market by Product
      • 5.1.3.4 Rest of North America Narcolepsy Therapeutics Market
        • 5.1.3.4.1 Rest of North America Narcolepsy Therapeutics Market by Type
        • 5.1.3.4.2 Rest of North America Narcolepsy Therapeutics Market by Product
  • 5.2 Europe Narcolepsy Therapeutics Market
    • 5.2.1 Europe Narcolepsy Therapeutics Market by Type
      • 5.2.1.1 Europe Narcolepsy with Cataplexy Market by Country
      • 5.2.1.2 Europe Narcolepsy Without Cataplexy Market by Country
      • 5.2.1.3 Europe Secondary Narcolepsy Market by Country
    • 5.2.2 Europe Narcolepsy Therapeutics Market by Product
      • 5.2.2.1 Europe Sodium Oxybate Market by Country
      • 5.2.2.2 Europe Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.2.2.3 Europe Central Nervous System Stimulants Market by Country
      • 5.2.2.4 Europe Tricyclic Antidepressants Market by Country
      • 5.2.2.5 Europe Others Market by Country
    • 5.2.3 Europe Narcolepsy Therapeutics Market by Country
      • 5.2.3.1 Germany Narcolepsy Therapeutics Market
        • 5.2.3.1.1 Germany Narcolepsy Therapeutics Market by Type
        • 5.2.3.1.2 Germany Narcolepsy Therapeutics Market by Product
      • 5.2.3.2 UK Narcolepsy Therapeutics Market
        • 5.2.3.2.1 UK Narcolepsy Therapeutics Market by Type
        • 5.2.3.2.2 UK Narcolepsy Therapeutics Market by Product
      • 5.2.3.3 France Narcolepsy Therapeutics Market
        • 5.2.3.3.1 France Narcolepsy Therapeutics Market by Type
        • 5.2.3.3.2 France Narcolepsy Therapeutics Market by Product
      • 5.2.3.4 Russia Narcolepsy Therapeutics Market
        • 5.2.3.4.1 Russia Narcolepsy Therapeutics Market by Type
        • 5.2.3.4.2 Russia Narcolepsy Therapeutics Market by Product
      • 5.2.3.5 Spain Narcolepsy Therapeutics Market
        • 5.2.3.5.1 Spain Narcolepsy Therapeutics Market by Type
        • 5.2.3.5.2 Spain Narcolepsy Therapeutics Market by Product
      • 5.2.3.6 Italy Narcolepsy Therapeutics Market
        • 5.2.3.6.1 Italy Narcolepsy Therapeutics Market by Type
        • 5.2.3.6.2 Italy Narcolepsy Therapeutics Market by Product
      • 5.2.3.7 Rest of Europe Narcolepsy Therapeutics Market
        • 5.2.3.7.1 Rest of Europe Narcolepsy Therapeutics Market by Type
        • 5.2.3.7.2 Rest of Europe Narcolepsy Therapeutics Market by Product
  • 5.3 Asia Pacific Narcolepsy Therapeutics Market
    • 5.3.1 Asia Pacific Narcolepsy Therapeutics Market by Type
      • 5.3.1.1 Asia Pacific Narcolepsy with Cataplexy Market by Country
      • 5.3.1.2 Asia Pacific Narcolepsy Without Cataplexy Market by Country
      • 5.3.1.3 Asia Pacific Secondary Narcolepsy Market by Country
    • 5.3.2 Asia Pacific Narcolepsy Therapeutics Market by Product
      • 5.3.2.1 Asia Pacific Sodium Oxybate Market by Country
      • 5.3.2.2 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.3.2.3 Asia Pacific Central Nervous System Stimulants Market by Country
      • 5.3.2.4 Asia Pacific Tricyclic Antidepressants Market by Country
      • 5.3.2.5 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Narcolepsy Therapeutics Market by Country
      • 5.3.3.1 China Narcolepsy Therapeutics Market
        • 5.3.3.1.1 China Narcolepsy Therapeutics Market by Type
        • 5.3.3.1.2 China Narcolepsy Therapeutics Market by Product
      • 5.3.3.2 Japan Narcolepsy Therapeutics Market
        • 5.3.3.2.1 Japan Narcolepsy Therapeutics Market by Type
        • 5.3.3.2.2 Japan Narcolepsy Therapeutics Market by Product
      • 5.3.3.3 India Narcolepsy Therapeutics Market
        • 5.3.3.3.1 India Narcolepsy Therapeutics Market by Type
        • 5.3.3.3.2 India Narcolepsy Therapeutics Market by Product
      • 5.3.3.4 South Korea Narcolepsy Therapeutics Market
        • 5.3.3.4.1 South Korea Narcolepsy Therapeutics Market by Type
        • 5.3.3.4.2 South Korea Narcolepsy Therapeutics Market by Product
      • 5.3.3.5 Singapore Narcolepsy Therapeutics Market
        • 5.3.3.5.1 Singapore Narcolepsy Therapeutics Market by Type
        • 5.3.3.5.2 Singapore Narcolepsy Therapeutics Market by Product
      • 5.3.3.6 Malaysia Narcolepsy Therapeutics Market
        • 5.3.3.6.1 Malaysia Narcolepsy Therapeutics Market by Type
        • 5.3.3.6.2 Malaysia Narcolepsy Therapeutics Market by Product
      • 5.3.3.7 Rest of Asia Pacific Narcolepsy Therapeutics Market
        • 5.3.3.7.1 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type
        • 5.3.3.7.2 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product
  • 5.4 LAMEA Narcolepsy Therapeutics Market
    • 5.4.1 LAMEA Narcolepsy Therapeutics Market by Type
      • 5.4.1.1 LAMEA Narcolepsy with Cataplexy Market by Country
      • 5.4.1.2 LAMEA Narcolepsy Without Cataplexy Market by Country
      • 5.4.1.3 LAMEA Secondary Narcolepsy Market by Country
    • 5.4.2 LAMEA Narcolepsy Therapeutics Market by Product
      • 5.4.2.1 LAMEA Sodium Oxybate Market by Country
      • 5.4.2.2 LAMEA Selective Serotonin Reuptake Inhibitor Market by Country
      • 5.4.2.3 LAMEA Central Nervous System Stimulants Market by Country
      • 5.4.2.4 LAMEA Tricyclic Antidepressants Market by Country
      • 5.4.2.5 LAMEA Others Market by Country
    • 5.4.3 LAMEA Narcolepsy Therapeutics Market by Country
      • 5.4.3.1 Brazil Narcolepsy Therapeutics Market
        • 5.4.3.1.1 Brazil Narcolepsy Therapeutics Market by Type
        • 5.4.3.1.2 Brazil Narcolepsy Therapeutics Market by Product
      • 5.4.3.2 Argentina Narcolepsy Therapeutics Market
        • 5.4.3.2.1 Argentina Narcolepsy Therapeutics Market by Type
        • 5.4.3.2.2 Argentina Narcolepsy Therapeutics Market by Product
      • 5.4.3.3 UAE Narcolepsy Therapeutics Market
        • 5.4.3.3.1 UAE Narcolepsy Therapeutics Market by Type
        • 5.4.3.3.2 UAE Narcolepsy Therapeutics Market by Product
      • 5.4.3.4 Saudi Arabia Narcolepsy Therapeutics Market
        • 5.4.3.4.1 Saudi Arabia Narcolepsy Therapeutics Market by Type
        • 5.4.3.4.2 Saudi Arabia Narcolepsy Therapeutics Market by Product
      • 5.4.3.5 South Africa Narcolepsy Therapeutics Market
        • 5.4.3.5.1 South Africa Narcolepsy Therapeutics Market by Type
        • 5.4.3.5.2 South Africa Narcolepsy Therapeutics Market by Product
      • 5.4.3.6 Nigeria Narcolepsy Therapeutics Market
        • 5.4.3.6.1 Nigeria Narcolepsy Therapeutics Market by Type
        • 5.4.3.6.2 Nigeria Narcolepsy Therapeutics Market by Product
      • 5.4.3.7 Rest of LAMEA Narcolepsy Therapeutics Market
        • 5.4.3.7.1 Rest of LAMEA Narcolepsy Therapeutics Market by Type
        • 5.4.3.7.2 Rest of LAMEA Narcolepsy Therapeutics Market by Product

Chapter 6. Company Profiles

  • 6.1 Jazz Pharmaceuticals plc
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional Analysis
    • 6.1.4 Research & Development Expenses
    • 6.1.5 Recent strategies and developments:
      • 6.1.5.1 Partnerships, Collaborations, and Agreements:
      • 6.1.5.2 Approvals and Trials:
  • 6.2 Shionogi & Co., Ltd.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Research & Development Expenses
  • 6.3 Teva Pharmaceutical Industries Ltd.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Regional Analysis
    • 6.3.4 Research & Development Expenses
  • 6.4 Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional & Segmental Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 Bioprojet
    • 6.5.1 Company Overview
    • 6.5.2 Recent strategies and developments:
      • 6.5.2.1 Partnerships, Collaborations, and Agreements:
  • 6.6 Takeda Pharmaceutical Company Limited
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Regional Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Ligand Pharmaceuticals, Inc.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Research & Development Expenses
  • 6.8 Graymark Healthcare, Inc.
    • 6.8.1 Company Overview